Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Study of D-Methadone in Patients With Chronic Pain

Phase 1

Completed

Conditions: Pain
CNS Cancer
Eye Cancer
Otorhinolaryngologic Neoplasms
Bladder Cancer
Esophageal Cancer
Pancreatic Cancer
Breast Cancer
Colon Cancer
Prostate Cancer

Interventions: Drug: D-methadone
Drug: placebo

First Posted Date: 2008-01-08

Last Posted Date: 2016-08-10

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 10

Registration Number: NCT00588640

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Long Term Follow-Up of Patients on Children's Cancer Group Protocols- (CCG-LTF1) FOLLOW-UP DATA

Completed

Conditions: Oncology
Pediatric Cancers

First Posted Date: 2008-01-08

Last Posted Date: 2013-10-09

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 102

Registration Number: NCT00588289

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Study of Bone Mineral Density in Postmenopausal Women After Treatment for Breast Cancer

Not Applicable

Completed

Conditions: Breast Cancer
Osteoporosis

Interventions: Other: Bone Mineral Density

First Posted Date: 2008-01-08

Last Posted Date: 2009-02-26

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT00587925

Locations: 🇺🇸
Memoral Sloan Kettering Cancer Center, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Estrogen, Diet, Genetics and Endometrial Cancer

Active, not recruiting

Conditions: Cancer
Endometrial Cancer
Corpus Uteri
Ovarian Cancer
Endometrium

Interventions: Behavioral: Questionnaire

First Posted Date: 2008-01-08

Last Posted Date: 2025-04-11

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1315

Registration Number: NCT00587886

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction

Completed

Conditions: Osteosarcoma

Interventions: Other: Blood draw

First Posted Date: 2008-01-08

Last Posted Date: 2011-09-02

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 59

Registration Number: NCT00588510

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

AIDS and Cancer Specimen Bank (ACSB)

Completed

Conditions: Kaposi's Sarcoma Classical
Non-Hodgkin's Lymphoma
Kaposi's Sarcoma AIDS Related
AIDS
HEMATOPOIETIC SYSTEM
Cancer

First Posted Date: 2008-01-08

Last Posted Date: 2011-04-21

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 65

Registration Number: NCT00587912

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Utility of PET In the Pre-Operative Assessment of Patients With Hepatic Colorectal Metastases

Completed

Conditions: Colorectal Carcinoma

First Posted Date: 2008-01-08

Last Posted Date: 2009-03-19

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 204

Registration Number: NCT00588549

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Sequential Administration of Oral 6-Thioguanine (6-TG) After Methotrexate (MTX) in Patients With Relapsed Hodgkin's Disease (Phase II)

Phase 2

Completed

Conditions: Hodgkin's Disease

Interventions: Drug: Methotrexate
Drug: Leucovorin calcium
Drug: 6-Thioguanine

First Posted Date: 2008-01-08

Last Posted Date: 2009-06-12

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 18

Registration Number: NCT00587873

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome

Recruiting

Conditions: Neuroblastoma

Interventions: Other: Tumor and Marrow Markers

First Posted Date: 2008-01-08

Last Posted Date: 2024-07-03

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 1500

Registration Number: NCT00588068

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Phase II Trial of Gemcitabine, Carboplatin, and Bevacizumab in Chemotherapy Naive Patients With Advanced/Metastatic Urothelial Carcinoma

Phase 2

Completed

Conditions: Urothelial Carcinoma
Cancer
Myeloproliferative Disorder

Interventions: Drug: Bevacizumab
Drug: Carboplatin
Drug: Gemcitabine

First Posted Date: 2008-01-08

Last Posted Date: 2016-01-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 51

Registration Number: NCT00588666

Locations: 🇺🇸
Memorial Sloan-Kettering Cancer Center @ Suffolk, Commack, New York, United States
🇺🇸
Memorial Sloan-Kettering Cancer Center at Mercy Medical Center, Rockville Centre, New York, United States
🇺🇸
Memoral Sloan Kettering Cancer Center@Phelps, Sleepy Hollow, New York, United States

and more 3 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy